Trace Neuroscience

London, England, United Kingdom · Biotechnology, Health Care · 1,000 employees

Trace Neuroscience is a biotech firm focused on developing new treatments for amyotrophic lateral sclerosis (ALS). The company was co-founded by notable professors from University College London and Stanford University. It is working on restoring the production of UNC13A, a crucial protein for neuronal communication which is lost in ALS patients. The recent funding aims to advance their lead progr

See plans & pricing → Track Trace Neuroscience’s funding, hiring, and signals — with verified contacts — on Fundz.